Utah Medical Products (UTMD) Equity Ratio (2010 - 2026)

Utah Medical Products' Equity Ratio history runs 17 years deep, the most recent figure standing at 0.97 for Q1 2026.

• In Q1 2026, Equity Ratio rose 1.3% year-over-year to 0.97; the TTM figure through Mar 2026 stood at 0.97 (up 1.3% YoY), while the FY2025 annual figure was 0.97, up 1.56% from the prior year.
• Equity Ratio was 0.97 for Q1 2026 at Utah Medical Products, down from 0.97 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.97 in Q4 2025 to a low of 0.91 in Q1 2022.
• Historically, Equity Ratio has averaged 0.95 across 5 years, with a median of 0.95 in 2023.
• The sharpest annual moves came in 2022 and 2023: Equity Ratio dropped 0.62% in 2022, then advanced 3.17% in 2023.
• A 5-year view of Equity Ratio shows it stood at 0.92 in 2022, then climbed by 2.7% to 0.95 in 2023, then rose by 1.17% to 0.96 in 2024, then climbed by 1.56% to 0.97 in 2025, then declined by 0.57% to 0.97 in 2026.
• The last three Equity Ratio figures came in at 0.97 (Q1 2026), 0.97 (Q4 2025), and 0.97 (Q3 2025), per Business Quant data.